Abstract
The possibility that cardiac failure may be an important contributory or additive factor has led to the sporadic use of digitalis in the treatment of the respiratory distress syndrome in newborn infants. To assess the value of such medication a double-blind controlled study was conducted on 196 newborn infants, using digoxin and a placebo. As a result of the findings in this study the routine use of digoxin for the prevention of the respiratory distress syndrome is not recommended. The toxic effects of digitalis are outlined.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DRISCOLL S. G., SMITH C. A. Neonatal pulmonary disorders. Pediatr Clin North Am. 1962 May;9:325–352. doi: 10.1016/s0031-3955(16)31259-7. [DOI] [PubMed] [Google Scholar]
- KAPLAN S. A caution about digoxin dosage in infants and young children. Pediatr Clin North Am. 1962 Nov;9:1159–1160. doi: 10.1016/s0031-3955(16)31347-5. [DOI] [PubMed] [Google Scholar]
- LENDRUM F. C. The pulmonary hyaline membrane as a manifestation of heart failure in the newborn infant. J Pediatr. 1955 Aug;47(2):149–156. doi: 10.1016/s0022-3476(55)80025-x. [DOI] [PubMed] [Google Scholar]
- LEVINE O. R., BLUMENTHAL S. Digoxin dosage in premature infants. Pediatrics. 1962 Jan;29:18–25. [PubMed] [Google Scholar]
- LEVINE O. R., SOMLYO A. P. Digitalis intoxication in premature infants. J Pediatr. 1962 Jul;61:70–78. doi: 10.1016/s0022-3476(62)80232-7. [DOI] [PubMed] [Google Scholar]